Real | Decreto 824/2010 !new!

The , of June 25, is the foundational piece of Spanish legislation regulating pharmaceutical laboratories, manufacturers of active substances, and the foreign trade of medicines. By integrating multiple European directives into a single framework, it ensures that all drugs—whether for human use, veterinary use, or research—meet strict safety and quality standards. Key Objectives of the Decree

: Establishing the Spanish Registry of Pharmaceutical Laboratories maintained by the AEMPS. Core Regulatory Requirements real decreto 824/2010

foreign trade of medicinal products. Boletín Oficial del Estado +1 If you are a professional in the pharma sector or a business looking to import/export medicines within Spain, this decree outlines your primary obligations to ensure patient safety and product efficacy. Boletín Oficial del Estado +1 Key Pillars of the Decree The regulation is designed to harmonize Spanish law with European standards, ensuring that every drug on the market is safe, effective, and of high quality. Boletín Oficial del Estado +1 Mandatory Authorizations The , of June 25, is the foundational

: Standardizing the rules for producing medicines and active pharmaceutical ingredients (APIs). Boletín Oficial del Estado +1 Mandatory Authorizations :